Market Tracker

03/27 6:01pm ET

Amgen Inc (NASDAQ:AMGN)

162.59
Delayed Data
As of Mar 27
 +2.04 / +1.27%
Today’s Change
108.20
Today|||52-Week Range
173.14
+2.07%
Year-to-Date

Today’s Trading

Previous close160.55
Today’s open161.26
Day’s range161.00 - 163.45
Volume2,438,867
Average volume (3 months)3,492,546
Market cap$123.4B
Dividend yield1.94%
Data as of 4:14pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+0.90%
Earnings growth (this year)+7.08%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)+7.30%
P/E ratio24.3
Price/Sales6.03
Price/Book4.80

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen+0.94+0.22%
GILDGilead Sciences-0.08-0.07%
BAXBaxter International...+0.53+0.78%
JUNOJuno Therapeutics In...+3.17+5.93%
Data as of 4:14pm ET, 03/27/2015

Financials

Next reporting dateApril 21, 2015
EPS forecast (this quarter)$2.11
Annual revenue (last year)$20.0B
Annual profit (last year)$5.2B
Net profit margin25.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Madhu Balachandran
Corporate headquarters
Thousand Oaks, California

Forecasts